Stevens: NICE process makes it 'harder' to strike deals with pharma

By Will Hazell2016-05-19T09:00:00

Authorisation of a drug by the National Institute for Health and Care Excellence can make it “harder” for NHS England to get a good deal from pharmaceutical companies, Simon Stevens has said.

You need to be a subscriber to read more

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

All HSJ news by sector, topic & region
Breaking News announcements
App for mobile and offline reading
Comment and Daily Insights newsletters
Regional roundup newsletters
Unrestricted access to ‘Ask HSJ’ - AI assistant - AI assistant
10 expert briefings every fortnight (Premium only)

to HSJ

Already a subscriber? Sign into your account here